Summary: “Chemo brain” — the cognitive fog, memory lapses, and mental fatigue that affect as many as 75% of people undergoing cancer treatment — has no established single treatment. A nationwide Phase 3 clinical trial now identifies a practical, low-cost intervention that helps protect thinking skills during chemotherapy: a personalized home-based exercise program called EXCAP.
The trial found that patients who followed a simple regimen of progressive walking and resistance-band exercises maintained their baseline physical activity and reported sharper thinking, while patients who did not receive a structured exercise prescription reduced daily movement by about 53% during treatment.
Key Facts
- EXCAP prescription: Developed in collaboration with the American College of Sports Medicine, EXCAP combines individualized, progressive aerobic walking with resistance band routines that match each patient’s abilities.
- Protection for the brain: Mild-to-moderate, consistent exercise reduced self-reported cognitive difficulties and improved executive functioning (tasks such as managing medications, finances, and household responsibilities) during chemotherapy.
- Activity decline without exercise: Patients who received usual care without a tailored exercise plan dropped their daily step counts by roughly 53% during chemotherapy, whereas those in the exercise group largely preserved their baseline activity.
- Stronger effects on two-week regimens: Benefits were most pronounced among patients on a two-week chemotherapy schedule, possibly because lower cumulative toxicity enabled more consistent activity.
- Anti-inflammatory mechanism: Evidence suggests exercise creates a systemic anti-inflammatory environment that supports immune function and may help prevent chemotherapy-related cognitive impairment.
Source: University of Rochester
Led by Karen Mustian, PhD, MPH, and Po-Ju Lin, PhD, MPH, RD, from the Wilmot Cancer Institute at the University of Rochester, the multicenter Phase 3 trial evaluated exercise as a supportive-care strategy to prevent or reduce cancer-related cognitive impairment (CRCI), commonly called “chemo brain.” The trial enrolled nearly 700 patients at 20 community oncology clinics across the United States. All participants were receiving chemotherapy for the first time for a variety of cancer diagnoses.
Participants were randomized to standard care without an exercise prescription or to a six-week, home-based EXCAP program delivered during chemotherapy. All patients recorded daily steps and any resistance-band exercises. Before starting chemotherapy, the average daily step count across participants was about 4,000 to 4,500 steps. During treatment, those without structured exercise typically walked less due to fatigue, weakness, nausea, or other side effects. In contrast, many patients who followed the EXCAP prescription maintained their typical daily step counts and reported fewer problems with thinking, memory, and mental fatigue.
Mustian emphasizes that EXCAP was designed to be practical, safe, and low-cost: home-based, personalized to physical ability, and built from progressive walking and resistance-band components. The program was created with exercise oncology professionals to ensure safety and effectiveness for people undergoing chemotherapy.
How exercise helps during chemotherapy
Exercise appears to protect cognitive function through multiple pathways. Regular physical activity reduces systemic inflammation, supports immune resilience, and helps preserve functional capacity and mood. These effects can reduce the severity of chemotherapy-related cognitive symptoms, including problems with attention, processing speed, memory, and planning. Importantly, the exercise used in this trial was mild to moderate in intensity; the benefit depended more on consistency and structure than on high effort.
Po-Ju Lin notes that a structured exercise prescription seems essential: without it, many patients substantially reduce activity and experience increased cognitive complaints. For patients who can adhere to a tailored program, EXCAP offers a feasible way to protect both physical activity levels and cognitive functioning during treatment.
Why some patients benefited more
The study found stronger effects among patients receiving chemotherapy every two weeks compared with those on three- or four-week cycles. Researchers do not yet know the exact reason; one possibility is that different drug regimens produce varying levels of cumulative toxicity and side effects, which can influence a patient’s ability to remain active. Further research is needed to clarify how chemotherapy schedule, drug type, and side-effect burden interact with exercise benefits.
Non-pharmacologic options matter
The investigators highlight that non-pharmacologic interventions — including structured exercise, cognitive training, and mindfulness — are practical, low-risk approaches to manage chemo brain. They can often be delivered at home and at low cost compared with clinic-based treatments. These approaches complement medical care and may be integrated into supportive oncology services.
Wilmot Cancer Institute provides evidence-based supportive services for patients, including exercise guidance, nutrition, mindfulness, and therapeutic resources to help patients stay active and manage symptoms during treatment.
Key Questions Answered:
A: Chemo brain describes a cluster of cognitive symptoms that many patients experience during and after chemotherapy: mental haze, trouble remembering names, losing one’s train of thought, difficulty concentrating, and trouble managing complex daily tasks such as paying bills or following instructions. These symptoms can meaningfully reduce quality of life.
A: No. The trial emphasizes mild-to-moderate activity that is consistent and structured. Maintaining a baseline of roughly 4,000 steps per day combined with simple resistance-band exercises can be sufficient to protect cognitive function in many patients.
A: Exercise reduces systemic inflammation and bolsters immune function, both of which are implicated in chemotherapy-related cognitive changes. By keeping the body more physically active, exercise helps regulate inflammatory responses and supports overall brain health.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full by the editorial team.
- Additional context was added by staff to clarify clinical implications and practical recommendations.
About this exercise and brain cancer research news
Author: Leslie Orr
Source: University of Rochester
Contact: Leslie Orr – University of Rochester
Image: Image credited to Neuroscience News
Original Research: Open access. “Effects of Exercise on Cognitive Impairment in Patients Receiving Chemotherapy: A Multicenter Phase III Randomized Controlled Trial” by Karen M. Mustian, Po-Ju Lin, Alisha Chakrabarti, Lindsey J. Mattick, Stephen Samuel, Umang Gada, Brian J. Altman, Paula M. Vertino, Amber S. Kleckner, Ian R. Kleckner, Joseph J. Guido, Chin-Shang Li, Luke J. Peppone, Charles S. Kamen, Kah Poh Loh, Steven R. Rousey, Adedayo A. Onitilo, Marianne Melnik, Supriya G. Mohile, and Michelle C. Janelsins. Journal of the National Comprehensive Cancer Network. DOI: 10.6004/jnccn.2025.7118
Abstract
Effects of Exercise on Cognitive Impairment in Patients Receiving Chemotherapy: A Multicenter Phase III Randomized Controlled Trial
Up to 75% of patients report cancer-related cognitive impairment (CRCI) during treatment and for years after therapy. CRCI commonly affects attention, verbal memory, executive function, and processing speed, and frequently co-occurs with mental fatigue. These deficits can impair daily functioning, reduce treatment adherence, and worsen overall prognosis. Currently, no gold-standard pharmacologic treatment exists for CRCI or related mental fatigue, which makes safe, accessible non-pharmacologic strategies like structured exercise an important focus for supportive cancer care.